Top 17 Ruipeng Pet Healthcare investors
The most complete profiles first. Showing 17 of 17.
David BonitaVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 93 more
Verified email available
Debbie LinVerified
Venture Capital, Corporate Venture Capital, Investor · United States
SeedHealth CareHospitalsWellnessWomen FoundedPortfolio: Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics and 36 more
Verified email available
Geoffrey HsuVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Johannes ZanzingerVerified
Venture Capital, Corporate Venture Capital, Investor · Germany
Series BSeries AHealth CareHospitalsWellnessWomen FoundedPortfolio: Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics and 36 more
Verified email available
Martin HeideckerVerified
Venture Capital, Corporate Venture Capital, Private Equity Firm · United States
SeedHealth CareHospitalsWellnessWomen FoundedPortfolio: Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics and 36 more
Verified email available
Detlev MennerichVerified
Corporate Venture Capital · Germany
Health CareHospitalsWellnessWomen FoundedPortfolio: Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics and 35 more
Verified email available
Jonathan SilversteinVerified
Private Equity Firm · United States
Health CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Jonathan WangVerified
Private Equity Firm · China
Health CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Rishi GuptaVerified
Private Equity Firm · United States
Health CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Carter Neild
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Chau Khuong
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Gennao Bio, Yisheng Biopharma and 89 more
Contact details available
Oliver Reuss
Venture Capital, Corporate Venture Capital, Investor · Germany
Series BSeries AHealth CareHospitalsWellnessWomen FoundedPortfolio: Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics and 35 more
Contact details available
Scotland Stevens
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Sebastian Kreuz
Venture Capital, Corporate Venture Capital, Investor · Germany
Series BSeries AHealth CareHospitalsWellnessWomen FoundedPortfolio: Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics and 35 more
Contact details available
Anat Naschitz
Private Equity Firm · Israel
Health CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Erez Chimovits
Private Equity Firm · Israel
Health CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Ilka Wicke Dr.
Corporate Venture Capital · Germany
Health CareHospitalsWellnessWomen FoundedPortfolio: Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics and 35 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
- Clover Biopharmaceuticals10
- ReViral10
- NeuroPace10
- Chinook Therapeutics10
- Aspen Neuroscience10
- I-Mab Biopharma10
- Achilles Therapeutics10
- MobileODT10
- Century Therapeutics10
- CoreMap10
- MBX Biosciences10
Frequently asked questions
How many Ruipeng Pet Healthcare investors are on Angel Roster?
Angel Roster lists 17 Ruipeng Pet Healthcare investors. 9 of them (53%) include a verified email address.
What types of investors are they?
The most common investor types are Private Equity Firms (11), Venture Capital Firms (10) and Corporate Venture Capital Firms (7). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Ruipeng Pet Healthcare investors invest in?
Among those that list a stage, the most common are Series A (8), Seed (7) and Series B (3).
Where are Ruipeng Pet Healthcare investors based?
Most are based in the United States (9), Germany (5) and Israel (2).
Which companies have Ruipeng Pet Healthcare investors backed?
The most-backed portfolio companies among them are Clover Biopharmaceuticals (10), ReViral (10), NeuroPace (10), Chinook Therapeutics (10) and Aspen Neuroscience (10).
How do I contact Ruipeng Pet Healthcare investors?
Create a free Angel Roster account to search and filter all 17, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.